发明名称 |
Base modified oligonucleotides |
摘要 |
The present invention relates to oligonucleotides with base modified nucleosides for enhancement of binding affinity. |
申请公布号 |
US9416360(B2) |
申请公布日期 |
2016.08.16 |
申请号 |
US201113883363 |
申请日期 |
2011.11.07 |
申请人 |
miRagen Therapeutics, Inc. |
发明人 |
Vagle Kurt;Dalby Christina;Marshall William S. |
分类号 |
C12N15/113;C12N15/11 |
主分类号 |
C12N15/113 |
代理机构 |
Cooley LLP |
代理人 |
Cooley LLP |
主权项 |
1. A base modified antisense oligonucleotide, comprising: at least one nucleotide having both:
a) a 2′ modification; and b) an amino carbonyl base modification at the C-5 position of a pyrimidine base, wherein the oligonucleotide is from about 5 to about 25 nucleotides in length and contains one or more phosphorothioate linkages; and wherein the 2′ modification is 2′-OMe and the amino carbonyl modified pyrimidine base has the following structure: wherein R is at least one member selected from the group consisting of: |
地址 |
Boulder CO US |